19
Views
7
CrossRef citations to date
0
Altmetric
Research Article

An Evaluation of Tricalcium Phosphate Excipients Particularly Using Instrumented Rotary and Single Station Tablet Presses

, , &
Pages 2693-2718 | Published online: 20 Oct 2008

References

  • Shangraw R. F., Wallace J. W., Bowers F. M. Pharm. Tech 1981; 5(10)69
  • Tri-Compress - An Outstanding Excipient. Edward Mendell Co., Inc., Carmel, NY, 10512
  • Tri-Tab, A New Direct Compression Excipient. Bulletin B-11457/6–82, Stauffer Chemical Co., Westport, CT, 06881
  • Loco-Tab, A New, Patented Direct Compression Tabletting Excipient. Ingredient Technology Corp., Pennsauken, NJ, 08110
  • Mendes R. W., Roy S. B. Pharm. Tech 1978; 2(9)61
  • Hou X. P., Carstensen J. T. J. Pharm. Sci 1985; 74: 466
  • Charlton B., Newton J. M. J. Pharm. Pharmacol 1984; 36: 645
  • Reier G. E., Shangraw R. F. J. Pharm. Sci 1966; 55: 510
  • Jerzewski R. L., Rudnic E. M. Pharm. Tech 1986; 10(9)32
  • D'Stefan D. A., Leesman G. D., Patel M. R., Morehead W. T. Drug Dev. and Ind. Pharm 1985; 11: 83
  • Patel J. J. Arnold & Marie Schwartz College of Pharmacy and Health Sciences. M. S. Thesis, Long Island University, Brooklyn, NY 1984, 11201
  • Sheth B. B., Bandelin F. J., Shangraw R. F. Pharmaceutical Dosage Forms: Tablets, H. A. Lieberman, L. Lachman. Marcel Dekker, New York 1980; Vol. 1: 109
  • Train D. J. Pharm. and Pharmacol 1956; 8: 745

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.